[Results of a randomized phase III study on treatment of recurrent glioblastoma: NovoTTF-100A versus chemotherapy] comment

Ergebnisse einer randomisierten Phase-III-Studie zur Behandlung rezidivierter Glioblastome: NovoTTF-100A versus Chemotherapie

Exposure

• • 200 kHz
  • electric field
  • intermediate frequency
• • therapeutic/medical device

Commented articles

• Stupp R et al. (2012): NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality